Who invested in OMEICOS Therapeutics?
OMEICOS Therapeutics's investors include Forbion Capital Partners and IBB Ventures.
Who invested in OMEICOS Therapeutics
Funding summaryUpdated 26 Oct 2026
$19Mraised across 1 round since 2018, from 1 source
- Latest round
- Series C, $19MNov 2018
- Investors
- 2
The rounds
- Nov 2018
Founders and team
From OMEICOS Therapeutics's own website: 5 on the team.
- Karen UhlmannVice President Operations
- Peter SeilerHead of Treasury Vice President SMS GmbH
- Robert FischerCEO/Cso
- Edita BadeHead of Finance
- Bernhard KirschbaumChairman
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about OMEICOS Therapeutics
How much has OMEICOS Therapeutics raised?
OMEICOS Therapeutics has raised $19M across 1 round since 2018.
When did OMEICOS Therapeutics last raise?
OMEICOS Therapeutics's most recent round was a Series C of $19M in Nov 2018.
What was OMEICOS Therapeutics's biggest round?
Its most recent round, $19M in Nov 2018, is also its largest on record.
Who backed OMEICOS Therapeutics first?
OMEICOS Therapeutics's first round on record, in Nov 2018, was backed by Forbion Capital Partners and IBB Ventures.
What stage is OMEICOS Therapeutics at?
OMEICOS Therapeutics's latest named round is a Series C, in Nov 2018.
Companies like OMEICOS Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.